The Singapore research team from RHB Research Group has downgraded UG Healthcare to “neutral” from “buy” with a lower discounted cash flow (DCF)-derived target price of 61 cents from 75 cents previously.

The downgrade comes as Malaysia announced the extension of Phase 1 of the National Recovery Plan (NRP1).

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook